Infection Surveillance Solutions Market - Global Industry Insights, Size, Share and Growth till 2023

Infection is the invasion and multiplication of microorganisms such as viruses, bacteria and parasites that are not normally present within the human body. An infection may cause no symptoms and be hidden, or it may cause symptoms and be clinically visible. An infection may remain localized, or it may spread through the blood or lymphatic vessels to become systemic (present in the entire body). The global infection surveillance solutions market is growing due to the emergence of diseases caused by microorganisms that were previously not known. The microorganisms living naturally within the body are not considered as infectious for example, bacteria that normally live within the mouth and intestine such as E. coli do not cause an infection to the body. Hospital associated infections such as urinary tract infection, surgical site infections and pneumonia are increasing due to the use of contaminated devices, patient clothing, and other materials used in hospitals and clinics. This has thus provoked healthcare professionals and hospitals to adopt infection surveillance solutions to identify possible infections during the time the patient remains in hospital, and to develop necessary preventive measures for the same. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sterile medical devices.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market/report-sample

Geographically, North America accounts for the largest market share in the global infection surveillance solutions market, which is attributable to the increasing occurrence of HAIs, favorable government policies for preventing HAIs, and rising healthcare expenditure in this region. Asia-Pacific region is expected to record the highest growth in the global market on account of rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvement in the health insurance sector in this region.

Various players in the infection surveillance solutions market are focusing on collaborating with other companies to expand their product and service offerings as well as introduction of new treatment methods into the infection surveillance solutions market.

In June, 2017, BD MAX, a newly developed molecular test of Becton, Dickinson and Company, received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for detecting intestinal bacteria that causes infectious diarrhea. The BD MAX was aimed at detecting majority of pathogens that cause acute gastroenteritis, ultimately leading to hospitalization.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=infection-surveillance-solutions-market

In June, 2017, Wolters Kluwer announced that Point of Care (POC) Advisor, its real-time clinical surveillance and analytics platform, was to integrate the Natural Language Processing (NLP) solution from Hiteks Solutions, Inc. for inclusion of unstructured and structured documentation to make them immediately come into action. The purpose of the integration was to enable real-time analysis of physician notes for infection sources, presence of one or more diseases occurring at the same time and other clues to the presence of sepsis.

Some of the other key players in global market are, Premier Inc., Baxter International Inc., Gojo Industries, Inc., Truven Health Analytics (An IBM Company), DEB Group Ltd., Hygreen, Inc., Atlas Medical Software, and RL Solutions.